Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Published:2011-07-14 Issue:3 Volume:19 Page:246-254
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

van der Loo J C M,Swaney W P,Grassman E,Terwilliger A,Higashimoto T,Schambach A,Baum C,Thrasher A J,Williams D A,Nordling D L,Reeves L,Malik P

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt2011102.pdf

Reference51 articles.

1. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415–419.

2. Williams DA, Baum C . Medicine. Gene therapy—new challenges ahead. Science 2003; 302: 400–401.

3. Howe SJ, Mansour MR, Schwarzwaelder K, Bartholomae C, Hubank M, Kempski H et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J Clin Invest 2008; 118: 3143–3150.

4. Schambach A, Mueller D, Galla M, Verstegen MM, Wagemaker G, Loew R et al. Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors. Gene Therapy 2006; 13: 1524–1533.

5. Yu SF, von Ruden T, Kantoff PW, Garber C, Seiberg M, Ruther U et al. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA 1986; 83: 3194–3198.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process;Cancer Gene Therapy;2023-06-30

2. Process intensification for lentiviral vector manufacturing using tangential flow depth filtration;Molecular Therapy - Methods & Clinical Development;2023-06

3. T cell-responsive macroporous hydrogels for in situ T cell expansion and enhanced antitumor efficacy;Biomaterials;2023-02

4. Institutional and infrastructure challenges for hospitals producing advanced therapies in the UK: the concept of ‘point-of-care manufacturing readiness’;Regenerative Medicine;2022-10

5. CAR Treg: A new approach in the treatment of autoimmune diseases;International Immunopharmacology;2022-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3